To extend our findings to human cells, we tested the levels of Ly6D and Ly6K proteins, which are upregulated in various tumor types 53, in 5 human tumor cell lines (HeLa, SiHa, CaSki, Detroit 562, and MCF-7) and showed their reduction after ASPH inhibition. Here, LY6K is linked to neoplasm.